BACKGROUND & AIMS:: Hepatosplenic T-cell lymphoma (HSTCL) is a rare and usually
fatal lymphoma that primarily affects men younger than 35 years old. Treatment of patients …

Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly
arises from a small subset of γ/δ T-cell receptor–expressing lymphocytes. HSTCL is more …

The World Health Organization classification of non‐Hodgkin lymphoma (NHL) was
introduced in 2001. However, its incorporation into clinical practice is not well‐described …

Hepatosplenic T-cell lymphoma (HSTCL) is a rare and clinically aggressive type of T-cell
lymphoma that arises most often in adolescents and young adults. Patients with HSTCL …

Background T‐cell lymphomas make up approximately 10%‐15% of lymphoid
malignancies. The frequency of these lymphomas varies geographically, with the highest …

Peripheral T-cell lymphomas (TCLs) are uncommon neoplasms, accounting for about 12%
of all lymphoid tumors worldwide. TCLs in which γδ T-cell receptors are expressed (γδ …

Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of T-cell lymphoma associated
with an aggressive clinical course and a worse prognosis. HSTCL develops in the setting of …

Background Hepatosplenic T-cell lymphoma (HSTCL) is a rare, lethal disease generally
seen in young male patients with inflammatory bowel disease. The study of biologic and …

Current guidelines recommend consolidation with autologous stem cell transplantation
(autoSCT) after induction chemotherapy for most patients with peripheral T-cell lymphoma …

Gamma‐delta T‐cell lymphomas are aggressive and rare diseases originating from gamma‐
delta lymphocytes. These cells, which naturally play a role in the innate, non‐specific …